Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,061,769
Closed -$176M 550
2020
Q3
$176M Sell
5,061,769
-1,244,950
-20% -$43.6M 1.86% 3
2020
Q2
$196M Sell
6,306,719
-1,208,178
-16% -$41M 1.79% 5
2020
Q1
$233M Buy
7,514,897
+418,829
+6% +$14.3M 2.09% 4
2019
Q4
$264M Sell
7,096,068
-371,188
-5% -$13.2M 1.56% 4
2019
Q3
$255M Sell
7,467,256
-2,465,808
-25% -$89.7M 1.48% 5
2019
Q2
$408M Sell
9,933,064
-207,309
-2% -$8.23M 2.12% 3
2019
Q1
$409M Sell
10,140,373
-355,862
-3% -$14.3M 2.11% 2
2018
Q4
$435M Sell
10,496,235
-1,212,896
-10% -$50.3M 2.44% 1
2018
Q3
$490M Sell
11,709,131
-2,401,346
-17% -$92.4M 2.31% 2
2018
Q2
$486M Sell
14,110,477
-809,556
-5% -$27.7M 2.24% 3
2018
Q1
$502M Sell
14,920,033
-294,863
-2% -$10.1M 2.3% 3
2017
Q4
$523M Sell
15,214,896
-339,160
-2% -$11.6M 2.25% 3
2017
Q3
$527M Sell
15,554,056
-1,096,326
-7% -$35.2M 2.29% 3
2017
Q2
$531M Sell
16,650,382
-701,926
-4% -$22.1M 2.26% 4
2017
Q1
$563M Sell
17,352,308
-487,762
-3% -$15.4M 2.33% 4
2016
Q4
$550M Sell
17,840,070
-171,249
-1% -$5.23M 2.26% 5
2016
Q3
$579M Buy
18,011,319
+284,162
+2% +$9.5M 2.47% 3
2016
Q2
$592M Sell
17,727,157
-404,481
-2% -$12.9M 2.63% 3
2016
Q1
$510M Sell
18,131,638
-1,266,645
-7% -$36.2M 2.21% 3
2015
Q4
$594M Buy
19,398,283
+95,831
+0.5% +$3.01M 2.58% 3
2015
Q3
$575M Sell
19,302,452
-215,309
-1% -$6.9M 2.64% 3
2015
Q2
$621M Buy
19,517,761
+19,495,627
+88,080% +$635M 2.65% 2
2015
Q1
$731K Sell
22,134
-34,877
-61% -$1.11M ﹤0.01% 419
2014
Q4
$1.69M Buy
57,011
+19,910
+54% +$571K 0.01% 344
2014
Q3
$1.04M Sell
37,101
-110,459
-75% -$3.1M ﹤0.01% 343
2014
Q2
$4.16M Buy
147,560
+125,004
+554% +$3.56M 0.02% 289
2014
Q1
$687K Sell
22,556
-9,802
-30% -$292K ﹤0.01% 347
2013
Q4
$940K Sell
32,358
-46,376
-59% -$1.35M ﹤0.01% 378
2013
Q3
$2.15M Sell
78,734
-7,774,831
-99% -$212M 0.01% 355
2013
Q2
$209M Buy
+7,853,565
New +$217M 0.97% 34

Other funds holding PFE

AJO LP's PFE Position: Q4 2020 in Review

AJO LP sold out of Pfizer (PFE) in Q4 2020, closing a stake of 5,061,769 shares — an estimated $176M sold.

AJO LP first reported a position in PFE in Q2 2013 and held it in 30 quarters. The position peaked at $621M in Q2 2015. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • AJO LP reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 5,061,769 Pfizer shares in Q4 2020, an estimated $176M.
  • AJO LP first reported a position in Pfizer in Q2 2013 and held it in 30 quarters.
  • AJO LP's Pfizer position peaked at $621M in Q2 2015.
  • 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.